Cantor Fitzgerald Reiterates “Neutral” Rating for Acadia Healthcare (NASDAQ:ACHC)

Acadia Healthcare (NASDAQ:ACHCGet Free Report)‘s stock had its “neutral” rating reaffirmed by equities researchers at Cantor Fitzgerald in a research note issued on Tuesday, Benzinga reports. They presently have a $90.00 price target on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 53.06% from the company’s current price.

A number of other analysts have also recently issued reports on ACHC. Deutsche Bank Aktiengesellschaft increased their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Barclays cut their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $86.67.

Check Out Our Latest Stock Report on ACHC

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $58.80 on Tuesday. The firm has a market capitalization of $5.46 billion, a PE ratio of -420.00, a P/E/G ratio of 2.19 and a beta of 1.30. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average price of $73.97 and a two-hundred day moving average price of $71.31. Acadia Healthcare has a twelve month low of $53.22 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. During the same period in the previous year, the business earned $0.92 EPS. Acadia Healthcare’s revenue was up 8.8% compared to the same quarter last year. Equities analysts forecast that Acadia Healthcare will post 3.51 EPS for the current year.

Institutional Trading of Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. bought a new position in Acadia Healthcare in the second quarter valued at $800,000. TCW Group Inc. raised its holdings in shares of Acadia Healthcare by 63.8% during the 2nd quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock valued at $4,247,000 after buying an additional 24,487 shares in the last quarter. SG Americas Securities LLC lifted its position in Acadia Healthcare by 435.6% in the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock worth $1,231,000 after buying an additional 14,824 shares during the last quarter. Principal Financial Group Inc. boosted its stake in Acadia Healthcare by 19.4% in the second quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after buying an additional 104,359 shares in the last quarter. Finally, Iron Triangle Partners LP grew its position in Acadia Healthcare by 3.5% during the fourth quarter. Iron Triangle Partners LP now owns 791,993 shares of the company’s stock valued at $61,585,000 after acquiring an additional 26,789 shares during the last quarter.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.